Cellular pathways mediating APO2L/TRAIL-induced apoptosis in glioma cells

被引：0
|
作者：
Rieger, J
Weller, M
Frank, B
Wick, W
机构：
[1] Mol Neurooncol Lab, Dept Gen Neurol, Tubingen, Germany
[2] Hertie Inst Clin Brain Res, Tubingen, Germany
来源：
NEURO-ONCOLOGY | 2005年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [21] Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis
    Lee, Dae-Hee
    Kim, Dong-Wook
    Lee, Hai-Chon
    Lee, Jung-Hyun
    Lee, Tae-Hwa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 446 (04) : 815 - 821
  • [22] Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
    Shipman, CM
    Croucher, PI
    BLOOD, 2002, 100 (11) : 208A - 208A
  • [23] Apo2L/TRAIL and immune regulation
    Anel, Alberto
    Bosque, Alberto
    Naval, Javier
    Pineiro, Andres
    Larrad, Luis
    Angeles Alava, Maria
    Jose Martinez-Lorenzo, Maria
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2074 - 2084
  • [24] TRAIL (Apo2L) induced apoptosis in human colon cancer cells is inhibited by ectopic expression of Bcl-2.
    Tang, XM
    Half, E
    Sinicrope, FA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1209S - 1209S
  • [25] Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis
    Balsas, Patricia
    Lopez-Royuela, Nuria
    Galan-Malo, Patricia
    Anel, Alberto
    Marzo, Isabel
    Naval, Javier
    BIOCHEMICAL PHARMACOLOGY, 2009, 77 (05) : 804 - 812
  • [26] Simultaneous in vitro exposure to STI-571, APO2L/TRAIL and interferon-alpha, with or without prior Ara-C treatment, APO2L/TRAIL-induced cytotoxicity and apoptosis in BCR/ABL plus leukemic blasts
    Martinelli, G
    Ottaviani, E
    Rosti, G
    Grafone, T
    Amabile, M
    Giannini, B
    Terragna, C
    Zardini, C
    Buonamici, S
    Soverini, S
    Trabacchi, E
    Bassi, S
    De Vivo, A
    Bonifazi, F
    Alberti, D
    Tura, S
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S34 - S34
  • [27] Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
    Almasan, A
    Ashkenazi, A
    CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (3-4) : 337 - 348
  • [28] Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis
    Atkins, GJ
    Bouralexis, S
    Evdokiou, A
    Hay, S
    Labrinidis, A
    Zannettino, ACW
    Haynes, DR
    Findlay, DM
    BONE, 2002, 31 (04) : 448 - 456
  • [29] Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
    Bouralexis, S
    Findlay, DM
    Atkins, GJ
    Labrinidis, A
    Hay, S
    Evdokiou, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 206 - 214
  • [30] Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
    S Bouralexis
    D M Findlay
    G J Atkins
    A Labrinidis
    S Hay
    A Evdokiou
    British Journal of Cancer, 2003, 89 : 206 - 214
12345